Moleculin Biotech, Inc. (MBRX)
0.4856
0.00 (0.00%)
USD |
NASDAQ |
Oct 05, 16:00
0.4856
0.00 (0.00%)
After-Hours: 20:00
Moleculin Biotech Market Cap : 3.448M for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.456M |
| October 01, 2026 | 3.577M |
| September 30, 2026 | 3.553M |
| September 29, 2026 | 3.737M |
| September 28, 2026 | 4.040M |
| September 25, 2026 | 4.271M |
| September 24, 2026 | 4.025M |
| September 23, 2026 | 3.748M |
| September 22, 2026 | 4.012M |
| September 21, 2026 | 3.693M |
| September 18, 2026 | 5.489M |
| September 17, 2026 | 5.538M |
| September 16, 2026 | 5.254M |
| September 15, 2026 | 5.336M |
| September 14, 2026 | 5.504M |
| September 11, 2026 | 5.076M |
| September 10, 2026 | 5.892M |
| September 09, 2026 | 5.432M |
| September 08, 2026 | 5.326M |
| September 04, 2026 | 5.040M |
| September 03, 2026 | 4.796M |
| September 02, 2026 | 4.927M |
| September 01, 2026 | 4.615M |
| August 31, 2026 | 4.577M |
| August 28, 2026 | 4.614M |
| Date | Value |
|---|---|
| August 27, 2026 | 4.890M |
| August 26, 2026 | 4.26M |
| August 25, 2026 | 4.338M |
| August 24, 2026 | 4.326M |
| August 21, 2026 | 4.210M |
| August 20, 2026 | 4.193M |
| August 19, 2026 | 4.061M |
| August 18, 2026 | 4.332M |
| August 17, 2026 | 4.310M |
| August 14, 2026 | 4.347M |
| August 13, 2026 | 4.056M |
| August 12, 2026 | 3.708M |
| August 11, 2026 | 3.160M |
| August 10, 2026 | 2.297M |
| August 07, 2026 | 2.185M |
| August 06, 2026 | 2.054M |
| August 05, 2026 | 2.081M |
| August 04, 2026 | 2.185M |
| August 03, 2026 | 2.268M |
| July 31, 2026 | 2.135M |
| July 30, 2026 | 5.443M |
| July 29, 2026 | 7.258M |
| July 28, 2026 | 11.69M |
| July 27, 2026 | 11.69M |
| July 24, 2026 | 11.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.460B |
| Alnylam Pharmaceuticals, Inc. | 29.41B |
| Savara, Inc. | 982.84M |
| Vericel Corp. | 2.104B |
| Biogen, Inc. | 33.01B |
Market Cap Related Metrics
| Price to Book Value | 0.2976 |
| Price | 0.4856 |
| Earnings Yield | -3.53K% |